by A Spanish study has preclinically tested a new type of immunotherapy against multiple myeloma
A new immunotherapy, STAb cell-basedhas been shown in the laboratory to be more effective than the currently preferred immunotherapy, CART-T cells, in the treatment of multiple myeloma, the second most common hematological cancer in adults.
According to the authors, this cell therapy was…
Report a bug
